Agenus logo

Agenus

AGEN | NASDAQ
Chart Builder DCF Calculator
$6.29
-$0.44 (-6.54%)
At close: Nov 16, 2026, 4:00 PM ET
$6.35
+$0.06 (+0.95%)
After-hours: Nov 16, 2026, 7:30 PM ET
-6.54%

Rating

Updated: Nov 16, 2026
65
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #90/1021 (Top 9%)

Key Statistics

Market Data

Market Cap $394.06M
1D Range
6.25 6.60
52W Range
2.77 9.93

Valuation (TTM)

PE 14.02
PB 45.33
EV/EBITDA 3.97

Valuation (NTM)

Forward PE 10.68
Forward PEG -0.05
Price Target $25.00
Loading financial charts...

Profile

Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes ...

Sector Healthcare
Industry Biotechnology
Employees 81
IPO Date Feb 8, 2000
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
$0.02
Beat +107.08%
REV
$31.5M
Beat +11.70%
Next Earnings
Mar 15, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$25.00
Upside
+297.46%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.